📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy. (2017)

First Author: Georgakopoulos ND

Attributed to: The Spatiotemporal Regulation of the Keap1/Nrf2 pathway funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-07679-7

PubMed Identifier: 28871145

Publication URI: http://europepmc.org/abstract/MED/28871145

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322